Bone Morphogenetic Protein Receptors, Type I
"Bone Morphogenetic Protein Receptors, Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of bone morphogenetic protein receptors with high affinity for BONE MORPHOGENETIC PROTEINS. They can interact with and undergo PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II. They signal primarily through RECEPTOR-REGULATED SMAD PROTEINS.
Descriptor ID |
D052005
|
MeSH Number(s) |
D08.811.913.696.620.682.700.109.500 D12.776.543.750.750.400.049.500
|
Concept/Terms |
Bone Morphogenetic Protein Receptors, Type I- Bone Morphogenetic Protein Receptors, Type I
- BMPR-I Receptors
- BMPR I Receptors
- Type I Bone Morphogenetic Protein Receptors
- BMP Type I Receptor
- Bone Morphogenetic Protein Receptor Type I
Bone Morphogenetic Protein Receptor, Type IA- Bone Morphogenetic Protein Receptor, Type IA
- Type IA Bone Morphogenetic Protein Receptor
- BMPR-IA Receptor
- BMPR IA Receptor
- Activin Receptor-Like Kinase 3
- Activin Receptor Like Kinase 3
- BMP Type IA Receptor
Bone Morphogenetic Protein Receptor, Type IB- Bone Morphogenetic Protein Receptor, Type IB
- Type IB Bone Morphogenetic Protein Receptor
- BMPR-IB Receptor
- BMPR IB Receptor
- Serine-Threonine Protein Kinase Receptor R6
- Serine Threonine Protein Kinase Receptor R6
- Activin Receptor-Like Kinase 6
- Activin Receptor Like Kinase 6
- BMP Type IB Receptor
|
Below are MeSH descriptors whose meaning is more general than "Bone Morphogenetic Protein Receptors, Type I".
Below are MeSH descriptors whose meaning is more specific than "Bone Morphogenetic Protein Receptors, Type I".
This graph shows the total number of publications written about "Bone Morphogenetic Protein Receptors, Type I" by people in this website by year, and whether "Bone Morphogenetic Protein Receptors, Type I" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 | 2008 | 1 | 0 | 1 | 2011 | 0 | 1 | 1 | 2013 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bone Morphogenetic Protein Receptors, Type I" by people in Profiles.
-
Mohedas AH, Xing X, Armstrong KA, Bullock AN, Cuny GD, Yu PB. Development of an ALK2-biased BMP type I receptor kinase inhibitor. ACS Chem Biol. 2013; 8(6):1291-302.
-
Steinbicker AU, Sachidanandan C, Vonner AJ, Yusuf RZ, Deng DY, Lai CS, Rauwerdink KM, Winn JC, Saez B, Cook CM, Szekely BA, Roy CN, Seehra JS, Cuny GD, Scadden DT, Peterson RT, Bloch KD, Yu PB. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood. 2011 May 05; 117(18):4915-23.
-
Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, Bouxsein ML, Hong DW, McManus PM, Katagiri T, Sachidanandan C, Kamiya N, Fukuda T, Mishina Y, Peterson RT, Bloch KD. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med. 2008 Dec; 14(12):1363-9.
-
Ma L, Lu MF, Schwartz RJ, Martin JF. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development. 2005 Dec; 132(24):5601-11.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|